LFUS enters the final stretch of Q3 with a deceptively simple setup: short sellers have been walking away for a month, borrowing costs are negligible, and the analyst community still sees meaningful upside — yet the stock is down 10% from its August peak and options traders are hedging with unusual patience.
The retreat in short positioning is the clearest move worth flagging. Short interest has fallen nearly 21% over the past six weeks, dropping from roughly 1.78 million shares borrowed in late August to about 1.22 million — cutting SI as a percentage of free float from a local peak above 7% to just under 5%. That unwind was not orderly: the bulk of the covering happened in a concentrated burst around August 20–25, suggesting tactical shorts closing rather than a structural shift. The borrow market reflects how uncrowded this name now is. Availability is essentially unlimited at over 4,300% — meaning more than 13 million shares remain available to lend against the roughly 1.2 million currently out — and the cost to borrow has drifted down to 0.41%, off about 19% over the past month. There is no meaningful squeeze pressure here. The ORTEX short score confirms the picture: at 39.4 and falling steadily from 43.9 three weeks ago, bearish conviction has eased across every dimension the model tracks.
Options tell a modestly different story. The put/call ratio at 1.70 is broadly in line with its 20-day average of 1.67, a z-score of just 0.28 — so there is no unusual hedging spike. But the absolute level of the PCR is worth noting: LFUS has traded with persistent put-heavy positioning throughout August, and the 52-week PCR range runs from a low of 0.17 to a high of 6.35. At 1.70, the market is not panicking, but it is not expressing much call enthusiasm either. The tone is neutral-to-cautious, consistent with a stock that rallied hard — up more than 65% year-to-date before August — and is now digesting that move.
The Street remains constructively positioned, though the most recent analyst data is from early July and should be read as background rather than current color. Heading into that point, targets clustered in the $500–$535 range, against a current price of $419. Baird carried an Outperform with a $535 target as of early June; Needham and Oppenheimer both held Buy/Outperform ratings in the same zone. The mean consensus target of $488.75 implies roughly 17% upside from here — notable given the stock has already run hard. The bull case centres on data centre circuit protection demand and electrification tailwinds; the bear case flags macro sensitivity and potential inventory rebuild cycles in the industrial and transportation segments. Valuation multiples have compressed with the pullback: the trailing PE has dropped about 3.2 points over 30 days to 22x, and EV/EBITDA has eased nearly 1.7 turns to 13.3x. Neither multiple is demanding for a name with a forward EPS growth factor ranking in the 98th percentile of its universe.
Institutional positioning shows no dramatic rotation. BlackRock is the largest holder at just under 10% of shares, and added 174,000 shares as of its last July filing. Invesco made the most notable move in recent quarters, adding 243,000 shares — a position build worth watching given the firm's active-management profile. The activist register carries only passive Vanguard 13G filings; no 13D filer has emerged. Insider activity over the past 90 days has been net negative at roughly $15.8 million in sales, but the composition matters: the meaningful sellers were the CFO and the Chief Accounting Officer exercising and selling options in mid-June, which are compensation-cycle transactions rather than directional bets. There are no open-market purchases of size to flag.
The next scheduled earnings release falls on October 27. The prior print on August 4 produced a 3.6% one-day gain and held those gains over the following week — a considerably quieter result than the July 29 special event that moved the stock 12.7% in a single session and 17.6% over five days. With short sellers already reduced and the stock 10% below its August highs, what to watch heading into Q3 results is whether the industrial and transportation recovery narratives — the segments most exposed to inventory and macro risk — show enough sequential improvement to justify the gap between current price and the analyst consensus sitting roughly $70 above it.
See the live data behind this article on ORTEX.
Open LFUS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
